Rascase Rasburicase 1.5mg Injection

1.5mg Injection in 1 Vial

4.5 (154)

₹750

Rascase 1.5mg Injection is likely rasburicase, a medication used to treat and prevent high uric acid levels (hyperuricemia) caused by chemotherapy in cancer patients, helping to protect the kidneys from damage. It works by converting uric acid into an inactive, more soluble substance called allantoin, which the body can then eliminate more easily, thereby lowering blood uric acid levels. It is administered as a slow intravenous injection by a doctor or nurse, with the dose and frequency determined based on the patient’s condition and treatment plan.

Description

Introduction Of Rascase 1.5mg Injection:

Rascase 1.5mg Injection contains Rasburicase, a recombinant urate-oxidase enzyme used to manage high uric acid levels (hyperuricemia) caused by tumor lysis syndrome in patients undergoing chemotherapy for leukemia, lymphoma, or other cancers.

Rascase 1.5mg Injection is administered only by a trained healthcare professional as an intravenous infusion, usually over about 30 minutes, using the diluent provided. Your doctor will decide the dose and duration, typically once daily for up to 5 days or until uric acid levels normalize. It should never be self-administered.

Nausea, vomiting, fever, and headache are among the most common effects of this medicine. This medicine is not suitable for patients with G6PD (glucose-6-phosphate dehydrogenase) deficiency, as it can cause serious blood-related reactions in such patients, so your doctor may test for this before starting treatment. Inform your doctor immediately if you notice hives, difficulty breathing, unusual fatigue, pale or bluish skin, or dark-colored urine.

Uses Of Rascase 1.5mg Injection:

  • Management of Tumor Lysis Syndrome
  • Prevention of hyperuricemia during chemotherapy for leukemia, lymphoma, and solid tumors

Benefits Of Rascase 1.5mg Injection:

1. Tumor Lysis Syndrome

When chemotherapy rapidly destroys cancer cells, it can release large amounts of uric acid into the blood, which may damage the kidneys. Rascase 1.5mg Injection quickly converts this excess uric acid into a more soluble compound, helping the kidneys clear it and reducing the risk of kidney injury.

2. Prevention of Kidney Complications in Cancer Patients

In patients at risk of tumor lysis syndrome during cancer treatment, Rascase 1.5mg Injection helps keep uric acid levels under control, supporting kidney function and allowing chemotherapy to continue safely.

Side effects of Rascase 1.5mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Rasburicase:

  • Nausea
  • Vomiting
  • Fever
  • Headache
  • Abdominal pain
  • Diarrhea
  • Constipation
  • Swelling (peripheral edema)
  • Anxiety

Machanism Of Action Of Rascase 1.5mg Injection:

Rascase Injection contains Rasburicase, a recombinant form of the enzyme urate oxidase. It works by converting uric acid into allantoin, a substance that is far more soluble than uric acid and can be easily excreted by the kidneys. This rapidly lowers blood uric acid levels, helping prevent the kidney damage and other complications associated with tumor lysis syndrome.

Contact Us

Info Table
Packaging Size 1 Vial + 1 Diluent Vial
Composition RASBURICASE-1.5MG
Manufacturer/Marketer SAYRE THERAPEUTICS
Consume Type Parenteral
Treatment Tumor Lysis Syndrome (Hyperuricemia)
Prescription/Non prescription Prescription
Form Injection (Lyophilised Powder, Single Use Vial)
Country of Origin Made in India
Vendor Info
Benefits
Reviews

Description

Introduction Of Rascase 1.5mg Injection:

Rascase 1.5mg Injection contains Rasburicase, a recombinant urate-oxidase enzyme used to manage high uric acid levels (hyperuricemia) caused by tumor lysis syndrome in patients undergoing chemotherapy for leukemia, lymphoma, or other cancers.

Rascase 1.5mg Injection is administered only by a trained healthcare professional as an intravenous infusion, usually over about 30 minutes, using the diluent provided. Your doctor will decide the dose and duration, typically once daily for up to 5 days or until uric acid levels normalize. It should never be self-administered.

Nausea, vomiting, fever, and headache are among the most common effects of this medicine. This medicine is not suitable for patients with G6PD (glucose-6-phosphate dehydrogenase) deficiency, as it can cause serious blood-related reactions in such patients, so your doctor may test for this before starting treatment. Inform your doctor immediately if you notice hives, difficulty breathing, unusual fatigue, pale or bluish skin, or dark-colored urine.

Uses Of Rascase 1.5mg Injection:

  • Management of Tumor Lysis Syndrome
  • Prevention of hyperuricemia during chemotherapy for leukemia, lymphoma, and solid tumors

Benefits Of Rascase 1.5mg Injection:

1. Tumor Lysis Syndrome

When chemotherapy rapidly destroys cancer cells, it can release large amounts of uric acid into the blood, which may damage the kidneys. Rascase 1.5mg Injection quickly converts this excess uric acid into a more soluble compound, helping the kidneys clear it and reducing the risk of kidney injury.

2. Prevention of Kidney Complications in Cancer Patients

In patients at risk of tumor lysis syndrome during cancer treatment, Rascase 1.5mg Injection helps keep uric acid levels under control, supporting kidney function and allowing chemotherapy to continue safely.

Side effects of Rascase 1.5mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Rasburicase:

  • Nausea
  • Vomiting
  • Fever
  • Headache
  • Abdominal pain
  • Diarrhea
  • Constipation
  • Swelling (peripheral edema)
  • Anxiety

Machanism Of Action Of Rascase 1.5mg Injection:

Rascase Injection contains Rasburicase, a recombinant form of the enzyme urate oxidase. It works by converting uric acid into allantoin, a substance that is far more soluble than uric acid and can be easily excreted by the kidneys. This rapidly lowers blood uric acid levels, helping prevent the kidney damage and other complications associated with tumor lysis syndrome.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Rascase Rasburicase 1.5mg Injection”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Rascase 1.5mg Injection used for?
Rasburicase 1.5mg Injection (Rascase) is used to treat and prevent high uric acid levels (hyperuricemia) caused by chemotherapy in cancer patients, helping protect the kidneys from damage.
It converts uric acid into an inactive, more soluble substance called allantoin, which the body can eliminate more easily, lowering blood uric acid levels.
It’s given as a slow intravenous injection by a doctor or nurse, with the dose and frequency determined based on your condition and treatment plan.
Certain cancers, like kidney or bladder cancer, combined with ongoing chemotherapy, can raise uric acid levels, which may worsen health outcomes if left untreated.
It’s manufactured by Sayre Therapeutics Pvt Ltd, supplied as a 1.5mg/ml vial in a box, made in India.
It works by breaking down uric acid in the blood, helping prevent kidney damage in cancer patients undergoing chemotherapy who have high uric acid levels. See MedlinePlus Drug Information for more.

Related products